Y.S.P. Southeast Asia Holding Berhad (KLSE:YSPSAH)

Market Cap	302.13M -7.4%
Revenue (ttm)	367.14M +1.6%
Net Income	24.19M -15.6%
EPS	0.17 -15.6%
Shares Out	141.84M
PE Ratio	12.50
Forward PE	n/a
Dividend	0.08 (3.76%)
Ex-Dividend Date	Dec 12, 2025

Volume	22,900
Average Volume	28,760
Open	2.120
Previous Close	2.090
Day's Range	2.120 - 2.120
52-Week Range	1.980 - 2.330
Beta	-0.01
RSI	58.61
Earnings Date	Feb 27, 2026

About KLSE:YSPSAH

Y.S.P. Southeast Asia Holding Berhad, together with its subsidiaries, engages in the manufacturing and trading of generic drugs in Malaysia, Singapore, Vietnam, Philippines, Cambodia, Myanmar, Brunei, Indonesia, Thailand, Africa, and internationally. It operates through three segments: Manufacturing, Trading, and Investment Holding. The company manufactures, sells, imports, exports, trades in, and distributes pharmaceutical and veterinary products, pharmaceutical fine chemicals, raw material, health food products, and medical devices. It also m...

• Industry: Pharmaceutical Preparations
• Founded: 1987
• Employees: 1,381
• Stock Exchange: Bursa Malaysia
• Ticker Symbol: YSPSAH

Financial Performance

In 2024, KLSE:YSPSAH's revenue was 368.66 million, an increase of 3.85% compared to the previous year's 355.00 million. Earnings were 26.69 million, a decrease of -28.48%.